Javad Shahidi

Senior Vice President, Biotech Unit BeOne Medicines

Dr. Javad Shahidi is a physician with a long track record in oncology drug development. For more than a decade, Dr. Shahidi has been leading the clinical development of multiple biologics including Antibody Drug Conjugates across various stages from pre-IND to global regulatory approvals. He currently serves as the Senior Vice President and Head of Biotech Unit at BeOne Medicines.

Seminars

Tuesday 24th February 2026
Panel Discussion: Evaluating the Cutting-Edge Innovation & Performance Driving ADC Differentiation & Progression Earlier Line Patient Therapies
8:00 am
  • Understanding the 2026 ADC landscape and how the bar has been raised to develop and deliver differentiated ADCs with meaningful patient impact
  • Assessing the need for novel ADC chemistry innovation: What is showing the most promise across novel payloads and conjugation technologies?
  • Discussing the potential of novel ADC biology approaches across bispecific targeting and antibody engineering to unlock next generation ADC therapies
  • Highlighting methods to best pursue ADC clinical differentiation across patient selections methods, combination strategies, and well executed clinical design
Javad Shahidi Speaker Photo - 16th World ADC London Summit